Protein-Bound Uremic Toxins: New Insight from Clinical Studies

By Liabeuf Sophie   Drüeke Tilman B.   Massy Ziad A.  

Toxins, Vol. 3, Iss. 7, 2011-07 ,pp. : 911-919

MDPI

Access to resources Recommend Favorite

Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins

By Florens Nans   Calzada Catherine   Lyasko Egor   Juillard Laurent   Soulage Christophe O.  

Toxins, Vol. 8, Iss. 12, 2016-12 ,pp. : 376-376

MDPI

Access to resources Recommend Favorite

The Aryl Hydrocarbon Receptor-Activating Effect of Uremic Toxins from Tryptophan Metabolism: A New Concept to Understand Cardiovascular Complications of Chronic Kidney Disease

By Sallée Marion   Dou Laetitia   Cerini Claire   Poitevin Stéphane   Brunet Philippe   Burtey Stéphane  

Toxins, Vol. 6, Iss. 3, 2014-03 ,pp. : 934-949

MDPI

Access to resources Recommend Favorite

Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149

By Boelaert Jente   Schepers Eva   Glorieux Griet   Eloot Sunny   Vanholder Raymond   Lynen Frédéric  

Toxins, Vol. 8, Iss. 11, 2016-10 ,pp. : 312-312

MDPI

Access to resources Recommend Favorite

Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149

By Tsikas Dimitrios   Beckmann Bibiana   Araujo Pedro  

Toxins, Vol. 8, Iss. 11, 2016-10 ,pp. : 311-311

MDPI

Access to resources Recommend Favorite